# Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols

> **NCT02933593** · NA · WITHDRAWN · sponsor: **St. Louis University**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Hydralazine
- **DRUG:** nifedipine

## Key facts

- **NCT ID:** NCT02933593
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI withdrew the protocol
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933593, "Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02933593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*